Vir Biotechnology (VIR) Change in Acquisitions & Divestments (2018 - 2026)

Vir Biotechnology (VIR) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $170.6 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 43.48% year-over-year to $170.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (down 26.09% YoY), and the FY2025 full-year result was $1.2 billion, down 30.91% from the prior year.
• Change in Acquisitions & Divestments retreated to $170.6 million in Q1 2026, from $342.9 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $715.7 million in Q4 2023 to a low of $84.8 million in Q3 2022.
• A 5-year average of $377.6 million and a median of $342.9 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments soared 427.69% in 2023 and plunged 57.93% in 2024, its largest moves.
• Tracing VIR's Change in Acquisitions & Divestments over 5 years: stood at $266.7 million in 2022, then soared by 168.39% to $715.7 million in 2023, then plunged by 57.93% to $301.1 million in 2024, then gained by 13.88% to $342.9 million in 2025, then sank by 50.25% to $170.6 million in 2026.
• Business Quant data shows VIR's Change in Acquisitions & Divestments at $170.6 million in Q1 2026, $342.9 million in Q4 2025, and $305.2 million in Q3 2025.